Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  iodine I 131 monoclonal antibody BC8
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-5 of 5 for your search:
Start Over
Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia
Phase: Phase II
Type: Treatment
Status: Completed
Age: 2 to 55
Sponsor: NCI, Other
Protocol IDs: 1297.00, FHCRC-1297.00, NCI-H99-0028, CDR0000067032, NCT00003868
Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic Leukemia
Phase: Phase II
Type: Treatment
Status: Completed
Age: 2 to 55
Sponsor: NCI, Other
Protocol IDs: 1298.00, FHCRC-1298.00, NCI-H99-0029, CDR0000067034, NCT00003870
Radiolabeled BC8 Antibody, Busulfan, Cyclophosphamide Followed by Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia in First Remission
Phase: Phase II
Type: Treatment
Status: Closed
Age: 16 to 55
Sponsor: NCI, Other
Protocol IDs: 1470.00, NCI-2013-01361, FHCRC-1470.00, NCI-H00-0056, 1470, CDR0000067778, P30CA015704, P01CA044991, NCT00005940
Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
Phase: Phase I
Type: Treatment
Status: Closed
Age: 50 and over
Sponsor: NCI, Other
Protocol IDs: 1432.00, NCI-2010-02046, 1432, P30CA015704, P01CA044991, FHCRC-1432.00, NCI-H00-0066, NCT00008177
Start Over